Vor Biopharma (VOR) Interest Expenses (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Interest Expenses data on file, last reported at $110000.0 in Q1 2026.

• On a quarterly basis, Interest Expenses fell 93.48% year-over-year to $110000.0 in Q1 2026; TTM through Mar 2026 was $10.5 million, a 56.94% increase from a year earlier, with the FY2025 full-year figure at $232.7 million, up 67.18% from the prior year.
• Interest Expenses for Q1 2026 stood at $110000.0, roughly flat from $110000.0 in the prior quarter.
• Over the last five years, Interest Expenses for VOR reached as high as $10.2 million in Q2 2025 and fell as low as $36000.0 in Q3 2025.
• Historically, Interest Expenses has averaged $1.6 million across 5 years, with a median of $1.3 million in 2022.
• Across the five-year window, Interest Expenses sank 99.65% in 2022 and soared 14465.71% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $2.7 million in 2022, then decreased by 11.85% to $2.4 million in 2023, then slipped by 29.65% to $1.7 million in 2024, then tumbled by 93.47% to $110000.0 in 2025, then changed by 0.0% to $110000.0 in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $110000.0 in Q1 2026, $110000.0 in Q4 2025, and $36000.0 in Q3 2025.